The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
CON · Healthcare · Shallow moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | SGRY | INGN | PCRX | CON |
|---|---|---|---|---|
| Moat Score (0–100) | 41 (highest) | 41 (highest) | 41 (highest) | 41 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 65 (highest) | 32 | 55 | 52 |
| Pricing power | 33 | 85 | 95 (highest) | — |
| Returns on capital | 4 | 11 | 4 | 87 (highest) |
| Balance-sheet safety | 40 | 55 (highest) | 28 | 7 |
| Capital allocation | 65 (highest) | 24 | 25 | 19 |
| No price data | No price data | 24% above value if growth stopped today (largest discount to value if growth stopped today) | 105% above value if growth stopped today | |
| Market cap | $2.0B | $167M | $1.1B | $4.1B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |